Dow-Chung Chi
Impact in
-
- Cancer Immunotherapy and Biomarkers
-
- Developmental Biology and Gene Regulation
- Congenital heart defects research
- Bone Metabolism and Diseases
- TGF-β signaling in diseases
- Hedgehog Signaling Pathway Studies
- Epigenetics and DNA Methylation
Papers in
-
- Sarcoma Diagnosis and Treatment 1
- Prostate Cancer Treatment and Research 1
- Oncology 3
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Kenro Kusumi (1 shared paper)Bruce W. Birren (1 shared paper)Wayne N. Frankel (1 shared paper)Roderick T. Bronson (1 shared paper)Jessica B. Spencer (1 shared paper)Eric S. Lander (1 shared paper)Eileen Sun (1 shared paper)Anne W. Kerrebrock (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)The Lancet Oncology (1 paper)Nature Genetics (1 paper)Breast Cancer Research and Treatment (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United States
In The Last Decade
Dow-Chung Chi
7 papers receiving 484 citations
Peers
Comparison fields: 5 of 58
- Oncology 139
- Molecular Biology 255
- Cancer Research 42
- Pulmonary and Respiratory Medicine 73
- Immunology 46
Countries citing papers authored by Dow-Chung Chi
This map shows the geographic impact of Dow-Chung Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dow-Chung Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dow-Chung Chi more than expected).
Fields of papers citing papers by Dow-Chung Chi
This network shows the impact of papers produced by Dow-Chung Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dow-Chung Chi. The network helps show where Dow-Chung Chi may publish in the future.
Co-authors
The 25 scholars most cited alongside Dow-Chung Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 237 | |
| 2 | 2018 | 114 | |
| 3 | 2017 | 70 | |
| 4 | 2021 | 24 | |
| 5 | Gemcitabine-induced pulmonary toxicity. | 2012 | 24 |
| 6 | 2020 | 20 | |
| 7 | 2014 | 1 |
About Dow-Chung Chi
Dow-Chung Chi is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 7 papers that have together received 490 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (1 paper), Prostate Cancer Treatment and Research (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Hormonal and reproductive studies (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Multiple Myeloma Research and Treatments (1 paper), TGF-β signaling in diseases (1 paper) and Cancer, Lipids, and Metabolism (1 paper). The work is most often cited by research in Oncology (139 citations), Molecular Biology (255 citations), Cancer Research (42 citations), Pulmonary and Respiratory Medicine (73 citations) and Immunology (46 citations). Dow-Chung Chi has collaborated with scholars based in United States. Frequent co-authors include Kenro Kusumi, Bruce W. Birren, Wayne N. Frankel, Roderick T. Bronson, Jessica B. Spencer, Eric S. Lander, Eileen Sun, Anne W. Kerrebrock, Richard Pazdur and Kirsten B. Goldberg. Their work appears in journals such as Clinical Cancer Research, The Lancet Oncology, Nature Genetics, Breast Cancer Research and Treatment and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.